Armata Pharmaceuticals (ARMP) Non Operating Interest Expenses (2013 - 2024)
Armata Pharmaceuticals (ARMP) recorded Non Operating Interest Expenses of $2.72 million in Q2 2024, up 49.3% from the prior quarter.
Powered by 
Analysis
Armata Pharmaceuticals (ARMP) Non Operating Interest Expenses (2013 - 2024) Analysis & Trends
On a TTM basis, Armata Pharmaceuticals' Non Operating Interest Expenses came in at $7.16 million as of Jun 30, 2024; for FY2023, it came in at $2.63 million.
- Annual Non Operating Interest Expenses has a five-year compound annual growth rate of 21.0% (FY2018 to FY2023).
- Across earlier years, Non Operating Interest Expenses came in at $100,000 in FY2021 (-84.1%), $628,000 in FY2020 (-32.5%) and $931,000 in FY2019 (-8.1%).
- The Q2 2024 figure is the highest quarterly Non Operating Interest Expenses in data going back to Q1 2013.
- Over the past five years, the year-over-year decline in Non Operating Interest Expenses ranged from 21.1% (Q3 2020) to 98.7% (Q3 2021).
- Per Business Quant, the preceding three quarters came in at $1.82 million (Q1 2024), $1.45 million (Q4 2023) and $1.18 million (Q3 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Armata Pharmaceuticals | 136.32 Mn | 84.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 2.72 Mn |
| Mar 31, 2024 | 1.82 Mn |
| Dec 31, 2023 | 1.45 Mn |
| Sep 30, 2023 | 1.18 Mn |
| Dec 31, 2021 | 36,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Mar 31, 2021 | 62,000.00 |
| Dec 31, 2020 | 128,000.00 |
| Sep 30, 2020 | 150,000.00 |
| Jun 30, 2020 | 142,000.00 |
| Mar 31, 2020 | 159,000.00 |
| Dec 31, 2019 | 205,000.00 |
| Sep 30, 2019 | 190,000.00 |
| Jun 30, 2019 | 230,000.00 |
| Mar 31, 2019 | 306,000.00 |
| Dec 31, 2018 | 337,000.00 |
| Sep 30, 2018 | 307,000.00 |
| Jun 30, 2018 | 281,000.00 |
| Sep 30, 2013 | 9,000.00 |
| Jun 30, 2013 | 128,000.00 |
API Access
Armata Pharmaceuticals Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ARMP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "ARMP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ARMP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();